Last reviewed · How we verify

NCT06299384

The Use of Voice-Based AI in 988 Crisis Counseling

Completed NA Last updated 6 April 2026
What this trial tests

NA trial testing LyssnCrisis in Suicide in 81 participants. Completed in 31 October 2025.

Timeline
2 April 2024
Primary endpoint
5 September 2025
31 October 2025

Quick facts

Lead sponsorLyssn.io, Inc.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposehealth services research
Enrollment81
Start date2 April 2024
Primary completion5 September 2025
Estimated completion31 October 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Lyssn.io, Inc. — full company profile →

Who can join

18 and older, any sex, with Suicide or Suicide and Self-harm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Effective training requires repeated opportunities for skills practice with performance-based feedback, which is challenging to provide at scale. This research study focuses on developing an AI-based, coding and feedback tool ("LyssnCrisis") for implementation in a nationally utilized crisis call center, training counselors (call-takers) in suicide risk assessment skills, and evaluating LyssnCrisis to improve services and client outcomes. This research study's goal is to maximize the human capacity of call-takers to help assess their callers for risk of suicidality, and thus, a core aspect of the current research is developing a novel training process that supports human call-taker capacities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Suicide

Currently open trials in the same condition.

Other Lyssn.io, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06299384.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing